JENNIFER TURNER: Open Payments
NPI 1821486465 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 80 payments from 24 companies in 2025. Trend: 2023 $1,794 · 2024 $1,493 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $471 |
| Amgen Inc. | 22 | $240 |
| Incyte Corporation | 1 | $124 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Dexcom, Inc. | 1 | $84 |
| ANI Pharmaceuticals, Inc. | 2 | $63 |
| GENZYME CORPORATION | 2 | $51 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: RINVOQ, KRYSTEXXA, Zynyz, VRAYLAR, SKYRIZI, BENLYSTA, Dexcom G6 Transmitter, OTEZLA.
Industry payments across AL — which companies pay providers there.
